Other serum biomarkers, such as peptides linked with eating behavior and metabolism, for instance, leptin and neuropeptide-Y, have been recently studied in the ALS-FTD continuum and show a promise as neurodegeneration biomarkers, but further investigations are needed to clarify their role in the pathophysiology of ALS and FTD (157). This evidence concerns the gene NPY and frontotemporal dementia.